Janis Davidson received her AA degree and RN from Los Angeles Valley College in Van Nuys, California. She received her Bachelor of Science in Nursing degree from Mt. St. Mary's College in Los Angeles. Her work experience ranges from ICU-CCU nurse, to teaching childbirth education courses. In 1990, she completed her Master of Science in Nursing degree and became a Certified Nurse Practitioner. Jan joined Allergy and Asthma Associates and Southern California Research in 1996 where she is a healthcare provider as well as a sub-investigator for pharmaceutical sponsored clinical trials.

Janis lives in Laguna Niguel and has 2 children.

EDUCATION:
1972-A.A. Los Angeles Valley College, Van Nuys, California
1977-B.S.N. Mount Saint Mary's College, Los Angeles, California
1992-M.S.N. California State University, Long Beach, California

POSTGRADUATE TRAINING:
1991 Preceptorship, Millers Hospital at Long Beach Memorial Medical Center California State University, Long Beach, California

LICENSES:
1. R.N., California, License #256324
2. N.P., California, License #5651

BOARD CERTIFICATIONS:
Pediatric Nurse Practitioner, National Association of Pediatric Nurse Associates and Practitioners (NAPNAP)

POSITIONS HELD:
1. Pediatric Nurse Practitioner, Saddleback Pediatrics, Mission Viejo, California, 1995-96
2. Pediatric Nurse Practitioner, Doctors of Children, Orange, California, 1991-95
3. Relief Charge Nurse, Post Partum/Nursery, Fountain Valley Regional Hospital, Fountain Valley, California, 1985-91
4. Childbirth Educator, Post Partum/Nursery/Education, Northridge Hospital, Northridge, California, 1978-85
5. Staff Nurse, CCU/ICU, Valley Presbyterian Hospital, Van Nuys, California, 1975-78

PROFESSIONAL ORGANIZATIONS:
Member, National Association of Pediatric Nurse Associates and Practitioners (NAPNAP)

RESEARCH ACTIVITIES: Associate Investigator

A 12-Week Comparison of Daily Doses of Drug 100 mcg and 200 mcg of Drug, an inhaler, Versus Placebo in the Autohaler Device in Pediatric Patients with Symptomatic Asthma

A Multicenter, Double Masked, Randomized, Parallel, Three-Month Study (With an Extention to One Year) of the Safety, Efficacy, and Acceptability Of 0.15% and 0.2% Eye Drops Compared with 0.2% Eye Drops in Subjects with Glaucoma or Ocular Hypertention

A Multicenter, Double-Masked, Randomized, Parallel Study of the Safety and Efficacy of Twice-Daily Dosed eye drop Combination Compared with Twice-Daily Dosed or Three-Times-Daily Dosed eye drops for Three Months (Plus 9-Month, Masked Extension) in Patients with Glaucoma or Ocular Hypertension

Inhaled Drug Treatment As Regular Therapy in Early Asthma

A Multicenter, Double-Blind,Randomized, Placebo-Controlled, Parallel Study to Assess the Safety and Tolerability of a Drug Twice a Day During Treatment of Children 2 Through 5 Years of Age with Allergic Rhinitis.

Prospective, Randomized, Double-Blind, Multi-Center Comparison of the Safety and Efficacy of an Antibiotic for Five Days Versus a Second Antibiotic for Seven Days in the Treatment of Patients with Acute Exacerbation of Chronic Bronchitis

An Open Label,Multi-Dose, Multicenter Study to Evaluate the Safety of an Inhaler and Reliability of the "To-Be-Marketed" Dry Powder Inhaler in Patients With Asthma

An Open Label Study to Evaluate the Safety of Topically Applied Ointment for the Treatment of Atop Dermatitis

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled 12-Week Study of Drug BID and Drug BID Delivered via CFC MDI and a Valved Holding Chamber with Facemask in Subjects with Asthma Age 24 Months to 47 Months

A Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Drug (250mcg QD) and Placebo in Subjects Greater than 12 years of Age with Chronic Asthma

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Study to Investigate the Efficacy and Safety of Inhaled Medication 10 Mg Administered Twice Daily for Five Days in the Treatment of Influenza in Patients 12 Years Or Over Diagnosed with Asthma Or Chronic Obstructive Pulmonary Disease

Efficacy and Safety of an Antihistamine in Subjects with Seasonal Allergic Rhinitis and Concurrent Asthma

Efficacy and Safety of an antihistamine in Patients with Perennial Allergic Rhinitis

Efficacy and Safety of an Antihistamine in the Treatment of Chronic Idiopathic Urticaria (CIU)

An Efficacy, Safety and Tolerability Study of Daily Dosing With an Nebulized Solution in Pediatric Subjects with Asthma

A Twelve-Month Safety Study of 30mg Antihistamine, QD in Normal Healthy Subjects

A Safety, Efficacy and Tolerability Study of Multiple Once-Daily Doses of a Drug Inhalation Solution in Subjects with Asthma

A Phase III, 7 Month Double-Blind, Randomized, Parallel-group, Placebo-Controlled, Multicenter Trial with a 5-Month Blind Extension Period to Assess Efficacy, Safety, Tolerability , Steroid-Reduction, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Drug in Adolescents and Adults with Moderate to Severe Allergic Asthma Requiring Daily Treatment of Inhaled Corticosteroids

A randomized, Double-blind, parallel group, placebo controlled multicenter study of the efficacy and safety of Drug vs Drug vs placebo in the treatment of subjects twelve years and older with seasonal allergic rhinitis.

An Observational Study to Assess Prevalence, Natural History, and Burden of Illness of Irritable Bowel Syndrome (IBS) in Clinical Practice and to Evaluate the Impact of Drug Treatment on Natural History and Burden of Illness in a Cohort of Females Whose Predominant Bowel Symptom is Diarrhea

PUBLICATIONS:

1. Davidson, J.K., (1992): Understanding Your Child With Asthma, An Informational Booklet for Parents.